2024

1. Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1

   JHEP Reports, Vol. 6, Núm. 1

2. Asociación Española de Neurogastroenterología y Motilidad (ASENEM) updated review on the management of functional abdominal pain

   Gastroenterologia y Hepatologia, Vol. 47, Núm. 8, pp. 888-900

3. Biallelic variants in SNUPN cause a limb girdle muscular dystrophy with myofibrillar-like features

   Brain, Vol. 147, Núm. 8, pp. 2867-2883

4. Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)

   Gut Microbes, Vol. 16, Núm. 1

5. Cirrhosis-downregulated LSECtin can be retrieved by cytokines, shifts the TLR-induced LSECs secretome and correlates with the hepatic Th response

   Liver International, Vol. 44, Núm. 4, pp. 996-1010

6. Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure

   Digestive and Liver Disease, Vol. 56, Núm. 10, pp. 1721-1729

7. Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry

   Therapeutic Advances in Gastroenterology, Vol. 17

8. Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry

   Journal of Crohn's & colitis, Vol. 18, Núm. 1, pp. 65-74

9. Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network

   Journal of Hepatology, Vol. 81, Núm. 4, pp. 630-640

10. Controversies in the management of anti-TNF therapy in patients with Crohn's disease: a Delphi consensus

    BMJ Open Gastroenterology, Vol. 11, Núm. 1

11. Curcumin encapsulated in milk small extracellular vesicles as a nanotherapeutic alternative in experimental chronic liver disease

    Biomedicine and Pharmacotherapy, Vol. 173

12. Demographic Trends in Liver Transplant Survivors after 3 Decades of Program Implementation: The Impact of Cohort and Period Effects on Life Expectancy

    Transplantation Direct, Vol. 10, Núm. 8, pp. e1684

13. Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism

    Frontiers in Endocrinology, Vol. 15

14. Drug-induced liver injury

    Sinusoidal Cells in Liver Diseases: Role in their Pathophysiology, Diagnosis, and Treatment (Elsevier Science Ltd.), pp. 193-212

15. Effectiveness and safety of a GLP-1 agonist in obese patients with inflammatory bowel disease

    Revista Espanola de Enfermedades Digestivas, Vol. 116, Núm. 9, pp. 478-483

16. Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis

    JHEP Reports, Vol. 6, Núm. 2

17. Fecal microbiota transplantation from female donors restores gut permeability and reduces liver injury and inflammation in middle-aged male mice exposed to alcohol

    Frontiers in Nutrition, Vol. 11

18. HIV infection is associated with a less aggressive phenotype of inflammatory bowel disease. A multicenter study of the ENEIDA registry.

    American Journal of Gastroenterology

19. Hepatic hemodynamic study: More than just HVPG measurement

    Gastroenterologia y Hepatologia

20. Identification of PRMT5 as a therapeutic target in cholangiocarcinoma

    Gut